Carol Midgley
- Molecular Biology top 2%
- Oncology top 0.5%
- Biotechnology top 0.5%
- Cancer Research top 5%
- Radiology, Nuclear Medicine and Imaging top 5%
- Co-authors
- David P. LaneTed R. HuppDavid W. MeekBořivoj VojtěšekJiří BártekSonia Laı́nJoana DesterroRonald T. Hay
- Topics
- Cancer-related Molecular Pathways (21 papers)Cancer Research and Treatments (10 papers)Ubiquitin and proteasome pathways (5 papers)
- Partner nations
- United KingdomCzechiaUnited States
In The Last Decade
Carol Midgley
30 papers receiving 4.6k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Molecular Biology 3.5k
- Oncology 3.0k
- Biotechnology 824
- Cancer Research 597
- Radiology, Nuclear Medicine and Imaging 461
Countries citing papers authored by Carol Midgley
This map shows the geographic impact of Carol Midgley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Midgley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Midgley more than expected).
Fields of papers citing papers by Carol Midgley
This network shows the impact of papers produced by Carol Midgley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Midgley. The network helps show where Carol Midgley may publish in the future.
Co-authorship network of co-authors of Carol Midgley
This figure shows the co-authorship network connecting the top 25 collaborators of Carol Midgley. A scholar is included among the top collaborators of Carol Midgley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol Midgley. Carol Midgley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 15 | |
| 2 | 95 | |
| 3 | 80 | |
| 4 | 53 | |
| 5 | 34 | |
| 6 | 212 | |
| 7 | 29 | |
| 8 | SUMO-1 modification activates the transcriptional response of p53breakdown → | 541 |
| 9 | 121 | |
| 10 | 35 | |
| 11 | 270 | |
| 12 | 5 | |
| 13 | 25 | |
| 14 | 40 | |
| 15 | 71 | |
| 16 | 31 | |
| 17 | 167 | |
| 18 | An immunochemical analysis of the human nuclear phosphoprotein p53breakdown → | 503 |
| 19 | Regulation of the specific DNA binding function of p53breakdown → | 800 |
| 20 | 113 |
About Carol Midgley
Carol Midgley is a scholar working on Biotechnology, Oncology and Molecular Biology, having authored 32 papers that have together received 4.8k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (21 papers), Cancer Research and Treatments (10 papers) and Ubiquitin and proteasome pathways (5 papers). The work is most often cited by research in Oncology (3.0k citations), Biotechnology (824 citations) and Molecular Biology (3.5k citations). Carol Midgley has collaborated with scholars based in United Kingdom, Czechia and United States. Frequent co-authors include David P. Lane, Ted R. Hupp, David W. Meek, Bořivoj Vojtěšek, Jiří Bártek, Sonia Laı́n, Joana Desterro, Ronald T. Hay, Manuel S. Rodríguez and Ian M. Tomlinson. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.